Close

Discovery on Target 2021 : Domain Therapeutics to present its latest developments and research

2021.09.20

Domain Therapeutics, a leading biopharmaceutical company focused on GPCR in immuno-oncology, is delighted to take part in the Discovery on Target 2021.

Do not miss this chance to stay on top of our latest developments and research ! Stay tuned for more !